<DOC>
	<DOCNO>NCT00377442</DOCNO>
	<brief_summary>This study assess potential pharmacokinetic interaction GK Activator ( 2 ) simvastatin , potential effect simvastatin glucose-lowering effect GK Activator ( 2 ) patient type 2 diabetes . Patients randomize one 6 treatment sequence receive single dos ) GK Activator ( 2 ) 100mg po , b ) simvastatin 80mg po c ) GK Activator ( 2 ) 100mg + simvastatin 80mg po . Dosing take place study day 1 , 8 15 , 7-14 day follow-up period last dose . The anticipated time study treatment &lt; 3 month , target sample size &lt; 100 individual .</brief_summary>
	<brief_title>A Drug-Drug Interaction Study GK Activator ( 2 ) Simvastatin Patients With Type 2 Diabetes .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>adult patient age 1875 year ; type 2 diabetes mellitus ; untreated , take antidiabetic statin therapy &gt; =2 week study start . type 1 diabetes mellitus , latent autoimmune diabetes adult ; diabetic neuropathy , retinopathy nephropathy ; patient treat insulin PPAR gamma agonist within 6 week screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>